XML 29 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 10 - Stock-based Compensation
6 Months Ended
Feb. 28, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
10.
       STOCK-BASED COMPENSATION
 
The Company has
two
stock-based compensation plans under which stock options and other stock-based awards have been granted, the Northern Technologies International Corporation Amended and Restated
2007
Stock Incentive Plan and the Northern Technologies International Corporation Employee Stock Purchase Plan (ESPP). The Compensation Committee of the Board of Directors and the Board of Directors administer these plans.
 
The
2007
Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, stock unit awards, performance awards and stock bonuses to eligible recipients to enable the Company and its subsidiaries to attract and retain qualified individuals through opportunities for equity participation in the Company, and to reward those individuals who contribute to the achievement of the Company’s economic objectives. Subject to adjustment as provided in the
2007
Plan, up to a maximum of
800,000
shares of the Company’s common stock are issuable under the
2007
Plan. Options granted under the
2007
Plan generally have a term of
ten
years and become exercisable over a
three
- or
four
-year period beginning on the
one
-year anniversary of the date of grant. Options are granted at per share exercise prices equal to the market value of the Company’s common stock on the date of grant. The Company issues new shares upon the exercise of options. As of
February 28, 2018,
only stock options and stock bonuses had been granted under the
2007
Plan.
 
The maximum number of shares of common stock of the Company available for issuance under the ESPP is
100,000
shares, subject to adjustment as provided in the ESPP. The ESPP provides for
six
-month offering periods beginning on
September 1
and
March 1
of each year. The purchase price of the shares is
90%
of the lower of the fair market value of common stock at the beginning or end of the offering period. This discount
may
not
exceed the maximum discount rate permitted for plans of this type under Section
423
of the Internal Revenue Code of
1986,
as amended. The ESPP is compensatory for financial reporting purposes.
 
The Company granted options to purchase an aggregate of
47,252
and
56,677
shares of its common stock during the
six
months ended
February 28, 2018
and
2017,
respectively. The fair value of option grants is determined at date of grant, using the Black-Scholes option pricing model with the assumptions listed below. The Company recognized compensation expense of
$206,534
and
$195,832
during the
six
months ended
February 28, 2018
and
2017,
respectively, related to the options that vested during such time period. As of
February 28, 2018,
the total compensation cost for nonvested options
not
yet recognized in the Company’s consolidated statements of operations was
$425,669.
Stock-based compensation expense of
$206,534
is expected through the remainder of fiscal year
2018,
and
$153,901
and
$65,234
is expected to be recognized during fiscal
2019
and fiscal
2020,
respectively, based on outstanding options as of
February 28, 2018.
Future option grants will impact the compensation expense recognized. Stock-based compensation expense is included in general and administrative expense on the consolidated statements of operations.
 
The fair value of each option grant is estimated on the grant date using the Black-Scholes option pricing model with the following assumptions and results for the grants:
 
   
Three and Six months ended
 
   
February 28,
2018
 
February 28,
2017
 
 
Dividend yield
2.18%
 
0.00%
 
 
Expected volatility
45.9%
 
46.4%
 
 
Expected life of option (in years)
10
 
10
 
 
Average risk-free interest rate
1.87%
 
1.63%
 
 
The weighted average per share fair value of options granted during the
six
months ended
February 28, 2018
and
2017
was
$7.75
and
$7.69,
respectively. The weighted average remaining contractual life of the options outstanding as of
February 28, 2018
and
2017
was
6.75
years and
6.91
years, respectively.